MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2967/jnumed.125.271770

Медицинская библиотека · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry.

Guberina Nika, Karpinski Madeleine J, Guberina Maja, Hoberück Sebastian, Miederer Matthias, Hölscher Tobias, Rauscher Isabel, Eiber Matthias, Nguyen Andrew, Theus Lela, Bauckneht Matteo, Scholtissek Helen, Rahbar Kambiz, Miksch Jonathan, Pizzuto Daniele Antonio, Goffin Karolien, Civan Caner, Reinwand Shima F, Stang Andreas, Kleesiek Jens, Merkel-Jens Anja, Umutlu Lale, Santangelo Alfonso, Soeterik Timo F W, Beintner-Skawran Stephan, Vondrak Andrej, Bjartell Anders, Evangelista Laura, Rasul Sazan, Miszczyk Marcin, Holzgreve Adrien, Sheikh Gabriel T, Di Giorgio Andrea, Farolfi Andrea, Herrmann Ken, Hadaschik Boris, Fendler Wolfgang P, Stuschke Martin

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

The impact of salvage radiotherapy (SRT) on overall survival (OS) in patients experiencing biochemical recurrence (BCR) of prostate cancer remains an area of active investigation. The international multicenter PROMISE registry provides a valuable dataset to explore the association between SRT and long-term clinical outcomes in this patient population (NCT06320223).

Methods

Comprehensive restaging at the time of BCR was performed by integrating both serologic markers and advanced molecular imaging (PET/CT or PET/MRI), offering an accurate assessment of molecular imaging (mi) TNM stage.

Results

In total, 1410 patients experiencing BCR with prior prostatectomy were included. The median follow-up was 5.2 y (interquartile range, 3.8-6.9 y). SRT was administered after PET to 381 of 680 patients (56.0%) with PET-negative disease (miT0N0M0) and to 478 of 730 patients (65.0%) with PET-locoregional disease (miT/N+ M0). SRT was associated with longer OS in the entire cohort (hazard ratio, 0.66; 95% CI, 0.47-0.93; P = 0.019) with 5- and 7-y survival rates of 95.2% (95% CI, 93.6%-96.8%) and 90.8% (95% CI, 88.1%-93.6%), respectively. Without SRT, 5- and 7-y survival rates were 92.1% (95% CI, 89.6%-94.7%) and 83.8% (95% CI, 79.8%-88.1%), respectively. Subgroup analysis found significant benefit for patients with miT0N0M0 disease (hazard ratio, 0.42; 95% CI, 0.22-0.78; P = 0.0061), particularly those with a prostate-specific antigen level of 0.5 ng/mL or lower (P = 0.03, log-rank test).

Conclusion

SRT improves OS for patients with BCR, especially those with a negative prostate-specific membrane antigen-targeted PET.

Для цитирования: Guberina Nika, Karpinski Madeleine J, Guberina Maja, Hoberück Sebastian, Miederer Matthias, Hölscher Tobias, Rauscher Isabel, Eiber Matthias, Nguyen Andrew, Theus Lela, Bauckneht Matteo, Scholtissek Helen, Rahbar Kambiz, Miksch Jonathan, Pizzuto Daniele Antonio, Goffin Karolien, Civan Caner, Reinwand Shima F, Stang Andreas, Kleesiek Jens, Merkel-Jens Anja, Umutlu Lale, Santangelo Alfonso, Soeterik Timo F W, Beintner-Skawran Stephan, Vondrak Andrej, Bjartell Anders, Evangelista Laura, Rasul Sazan, Miszczyk Marcin, Holzgreve Adrien, Sheikh Gabriel T, Di Giorgio Andrea, Farolfi Andrea, Herrmann Ken, Hadaschik Boris, Fendler Wolfgang P, Stuschke Martin. Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026. DOI: 10.2967/jnumed.125.271770.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.